Balanced news tone
News Sentiment
GUD sentiment intelligence
Knight Therapeutics Inc. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
News tone and price action are not far from neutral.
85/100 classification confidence.
directly relevant articles
high-authority source matches
-1.1% over one week, +3.4% over four weeks, trend active, and materially above fair value.
Knight Therapeutics (TSX:GUD) Expands Latin America Specialty Pharma Platform
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Knight Therapeutics (TSX:GUD) Expands Latin America Specialty Pharma Platform
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 16 Jul 2026 20:57
- Source
- Kalkine Media
What's Going On With Knight Therapeutics Inc. Stock Wednesday?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Jul 2026 14:31
- Source
- Wealth Awesome
Knight Therapeutics (TSX:GUD) Deepens Its LatAm Reach
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 14 Jul 2026 18:26
- Source
- Kalkine Media
Knight Announces Early Warning Filing Regarding Shares of Crescita
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 06 Jun 2026 07:00
- Source
- The Manila Times
This analyst just upped his price target on Knight Therapeutics
- Tone
- Neutral 50/100
- Event
- Analyst action
- Published
- 08 May 2026 07:00
- Source
- Cantech Letter
Knight Therapeutics Reports First Quarter 2026 Results
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 07 May 2026 07:00
- Source
- GlobeNewswire
Knight Therapeutics Number of Employees 2026 | Employee Count & Headcount Data
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 06 May 2026 07:15
- Source
- Revelio Labs
Knight Therapeutics Inc. ranks on The Globe and Mail’s second annual Canada’s Top Growing Women-Led Companies and seventh annual Women Lead Here benchmark of executive gender diversity
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 27 Mar 2026 07:00
- Source
- Market source
TSX Value Picks Knight Therapeutics And 2 Other Stocks Estimated Below Intrinsic Value
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 25 Mar 2026 07:00
- Source
- simplywall.st
Knight Amends Normal Course Issuer Bid
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 23 Mar 2026 07:00
- Source
- The Manila Times
This analyst just raised his price target on Knight Therapeutics
- Tone
- Neutral 50/100
- Event
- Analyst action
- Published
- 22 Mar 2026 07:00
- Source
- Cantech Letter
Knight Therapeutics Q4 Profit Tests Bullish Earnings Narrative After Yearlong Loss
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 20 Mar 2026 07:00
- Source
- simplywall.st
Knight Therapeutics is a buy, Stifel says
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 09 May 2025 07:00
- Source
- Cantech Letter
Knight Therapeutics to buy Paladin Pharma in bid to build out Canadian business
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 11 Mar 2025 07:00
- Source
- The Globe and Mail
Knight Therapeutics (TSE:GUD) investors are sitting on a loss of 33% if they invested five years ago
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 14 Dec 2022 08:00
- Source
- Market source
GUD.CA News | KNIGHT THERAPEUTICS INC (TSX:GUD)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 Jan 2020 17:48
- Source
- ChartMill
Knight Therapeutics buys Latin American drug firm for $418-million in first major acquisition
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 21 Oct 2019 07:00
- Source
- The Globe and Mail
Knight Therapeutics (GUD) Stock Price, News & Analysis $GUD
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 12 Aug 2016 11:14
- Source
- MarketBeat